Rural Health
Resources by Topic: Substance use and misuse
Patterns of Buprenorphine Use and Risk for Re-Arrest among Highly Vulnerable Opioid-Involved Women Released from Jails in Rural Appalachia
Study examining licit and illicit use of buprenorphine by women in the Appalachia region of Kentucky with moderate to severe opioid involvement who had recently been released from jail. Discusses the role of consistent healthcare services in relation to risk for re-arrest, presenting data on demographics, opioid use, and healthcare access over a 3-month tracking period.
Author(s): Hilary L. Surratt, Michele Staton, Carl G. Leukefeld, Carrie B. Oser, J. Matthew Webster
Citation: Journal of Addictive Diseases, 37(1-2), 1-4
Date: 12/2018
view details
Study examining licit and illicit use of buprenorphine by women in the Appalachia region of Kentucky with moderate to severe opioid involvement who had recently been released from jail. Discusses the role of consistent healthcare services in relation to risk for re-arrest, presenting data on demographics, opioid use, and healthcare access over a 3-month tracking period.
Author(s): Hilary L. Surratt, Michele Staton, Carl G. Leukefeld, Carrie B. Oser, J. Matthew Webster
Citation: Journal of Addictive Diseases, 37(1-2), 1-4
Date: 12/2018
view details
Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment
Examines the disparity of Neonatal Abstinence Syndrome (NAS) prevalence in Appalachian and non-Appalachian Kentucky and in comparison to national data. Considers why data from this study may or may not be useful in identifying regional and national trends. Also discusses the challenges of providing substance use treatment to pregnant women and Appalachian populations.
Author(s): Joshua D. Brown, Amie J. Goodin, Jeffrey C. Talbert
Citation: Journal of Rural Health, 34(1), 6-13
Date: 12/2018
view details
Examines the disparity of Neonatal Abstinence Syndrome (NAS) prevalence in Appalachian and non-Appalachian Kentucky and in comparison to national data. Considers why data from this study may or may not be useful in identifying regional and national trends. Also discusses the challenges of providing substance use treatment to pregnant women and Appalachian populations.
Author(s): Joshua D. Brown, Amie J. Goodin, Jeffrey C. Talbert
Citation: Journal of Rural Health, 34(1), 6-13
Date: 12/2018
view details
Trend Differences in Men and Women in Rural and Urban U.S. Settings
Highlights a study on differences in rates of smoking between men and women in rural and urban areas across the U.S. Details age, income, and several other indicators that may contribute to rates of smoking.
Author(s): A. Cepeda-Benito, N.J. Doogan, R. Redner, et al.
Citation: Preventive Medicine, 117, 69-75
Date: 12/2018
view details
Highlights a study on differences in rates of smoking between men and women in rural and urban areas across the U.S. Details age, income, and several other indicators that may contribute to rates of smoking.
Author(s): A. Cepeda-Benito, N.J. Doogan, R. Redner, et al.
Citation: Preventive Medicine, 117, 69-75
Date: 12/2018
view details
Support and Sabotage: A Qualitative Study of Social Influences on Health Behaviors among Rural Adults
Examines the impact of social relationships on health behavior adoption and maintenance by interviewing midlife and older adults in rural Montana at increased risk of chronic disease. Addresses family and peer influences on diet, physical activity, and tobacco use.
Author(s): Urshila Sriram, Emily H. Morgan, Meredith L. Graham, Sara C. Folta, Rebecca A. Seguin
Citation: Journal of Rural Health, 34(1), 88-97
Date: 12/2018
view details
Examines the impact of social relationships on health behavior adoption and maintenance by interviewing midlife and older adults in rural Montana at increased risk of chronic disease. Addresses family and peer influences on diet, physical activity, and tobacco use.
Author(s): Urshila Sriram, Emily H. Morgan, Meredith L. Graham, Sara C. Folta, Rebecca A. Seguin
Citation: Journal of Rural Health, 34(1), 88-97
Date: 12/2018
view details
Evaluating Coverage of Selected Domains in the National Survey on Drug Use and Health: NSDUH Methodological Report
Highlights the methodological parameters of the National Survey on Drug Use and Health study. Includes selection information for rural and American Indian and Alaska Native groups.
Date: 12/2018
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Highlights the methodological parameters of the National Survey on Drug Use and Health study. Includes selection information for rural and American Indian and Alaska Native groups.
Date: 12/2018
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Pandora's Pill Bottle - 1: Opioids in Rural America
Presents a series of articles on the effect the opioid crisis has had on rural agricultural areas. Details the stories of rural people whose lives have been affected by opioids.
Additional links: Pandora's Pill Bottle - 2: How Opioids Become a Problem, Pandora's Pill Bottle - 3: Impact of Opioids, Pandora's Pill Bottle - 4: Battling Opioids at Ground Level, Pandora's Pill Bottle - 5: A Life of Hope Lost to Opioid Addiction, Pandora's Pill Bottle - 6: What Needs to be Done About Opioids?, Pandora's Pill Bottle - 7: Actionable Insights for Local Communities Against Opioid Abuse
Author(s): Todd Neeley
Date: 12/2018
view details
Presents a series of articles on the effect the opioid crisis has had on rural agricultural areas. Details the stories of rural people whose lives have been affected by opioids.
Additional links: Pandora's Pill Bottle - 2: How Opioids Become a Problem, Pandora's Pill Bottle - 3: Impact of Opioids, Pandora's Pill Bottle - 4: Battling Opioids at Ground Level, Pandora's Pill Bottle - 5: A Life of Hope Lost to Opioid Addiction, Pandora's Pill Bottle - 6: What Needs to be Done About Opioids?, Pandora's Pill Bottle - 7: Actionable Insights for Local Communities Against Opioid Abuse
Author(s): Todd Neeley
Date: 12/2018
view details
Drug, Opioid-Involved, and Heroin-Involved Overdose Deaths Among American Indians and Alaska Natives — Washington, 1999–2015
Reports on trends and disparities in drug, opioid-involved, and heroin-involved overdose mortality rates for American Indian/Alaska Native (AI/AN) and non-Hispanic White people in Washington state. Includes data on total overdose deaths for AI/AN and White people by county of residence for metropolitan and nonmetro counties.
Author(s): Sujata Joshi, Thomas Weiser, Victoria Warren-Mears
Citation: MMWR (Morbidity and Mortality Weekly Report), 67(50), 1384-1387
Date: 12/2018
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on trends and disparities in drug, opioid-involved, and heroin-involved overdose mortality rates for American Indian/Alaska Native (AI/AN) and non-Hispanic White people in Washington state. Includes data on total overdose deaths for AI/AN and White people by county of residence for metropolitan and nonmetro counties.
Author(s): Sujata Joshi, Thomas Weiser, Victoria Warren-Mears
Citation: MMWR (Morbidity and Mortality Weekly Report), 67(50), 1384-1387
Date: 12/2018
Sponsoring organization: Centers for Disease Control and Prevention
view details
Red Flags and Warning Signs Ignored: Opioid Distribution and Enforcement Concerns in West Virginia
Report highlights a U.S. House Committee on Energy and Commerce investigation into the opioid crisis in West Virginia. Examines the policies of the various drug distribution companies who shipped opioids into the state, as well as the effectiveness of the Drug Enforcement Administration's (DEA) oversight.
Date: 12/2018
Sponsoring organization: House Committee on Energy and Commerce
view details
Report highlights a U.S. House Committee on Energy and Commerce investigation into the opioid crisis in West Virginia. Examines the policies of the various drug distribution companies who shipped opioids into the state, as well as the effectiveness of the Drug Enforcement Administration's (DEA) oversight.
Date: 12/2018
Sponsoring organization: House Committee on Energy and Commerce
view details
Public Health and Other Related Provisions in P.L 115-271, the SUPPORT for Patients and Communities Act
Summarizes Title VII and VIII provisions in the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act). Addresses provisions affecting access to opioid misuse treatment and providers, data collection, child welfare, the Department of Justice, substance use prevention, and more. Sections highlighting rural authorize grants for first responder training, data collection on adverse childhood experiences, recovery support services, and reauthorization of the State and Tribal Response to the Opioid Abuse Crisis grant program with technical assistance for rural and underserved communities.
Date: 12/2018
Sponsoring organization: Congressional Research Service
view details
Summarizes Title VII and VIII provisions in the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act). Addresses provisions affecting access to opioid misuse treatment and providers, data collection, child welfare, the Department of Justice, substance use prevention, and more. Sections highlighting rural authorize grants for first responder training, data collection on adverse childhood experiences, recovery support services, and reauthorization of the State and Tribal Response to the Opioid Abuse Crisis grant program with technical assistance for rural and underserved communities.
Date: 12/2018
Sponsoring organization: Congressional Research Service
view details
Buprenorphine and the Opioid Crisis: A Primer for Congress
Discusses the use of buprenorphine in Medication-Assisted Treatment (MAT) of opioid addiction. Report addresses questions for U.S. lawmakers to craft opioid treatment policy. Looks at the effectiveness, demand, and access of buprenorphine.
Date: 12/2018
Sponsoring organization: Congressional Research Service
view details
Discusses the use of buprenorphine in Medication-Assisted Treatment (MAT) of opioid addiction. Report addresses questions for U.S. lawmakers to craft opioid treatment policy. Looks at the effectiveness, demand, and access of buprenorphine.
Date: 12/2018
Sponsoring organization: Congressional Research Service
view details